Article Text

Download PDFPDF
Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors JZ and C-HL participated in follow-up, provided the figure and wrote the manuscript. JZ performed statistical analysis. C-HL and YW collected the clinical data at baseline. JZ, C-HL and YS helped to prepared the table. JZ, YS and J-LG provided critical revisions to the manuscript. J-LG designed the study, contributed to the discussion and edited the manuscript. All authors read and approved the final manuscript.

  • Funding This work was supported by the National Natural Science Foundation of China (81871276).

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles